Orthocell Limited OCC.AX Stock
Orthocell Limited Price Chart
Orthocell Limited OCC.AX Financial and Trading Overview
| Orthocell Limited stock price | 0.38 AUD |
| Previous Close | 0.35 AUD |
| Open | 0.35 AUD |
| Bid | 0.35 AUD x 0 |
| Ask | 0.36 AUD x 0 |
| Day's Range | 0.35 - 0.36 AUD |
| 52 Week Range | 0.3 - 0.51 AUD |
| Volume | 82.12K AUD |
| Avg. Volume | 107.92K AUD |
| Market Cap | 71.03M AUD |
| Beta (5Y Monthly) | 0.236781 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.04 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 0.55 AUD |
OCC.AX Valuation Measures
| Enterprise Value | 41.71M AUD |
| Trailing P/E | N/A |
| Forward P/E | -7.2000003 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 43.99494 |
| Price/Book (mrq) | 11.612904 |
| Enterprise Value/Revenue | 25.833 |
| Enterprise Value/EBITDA | -3.882 |
Trading Information
Orthocell Limited Stock Price History
| Beta (5Y Monthly) | 0.236781 |
| 52-Week Change | 7.81% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.51 AUD |
| 52 Week Low | 0.3 AUD |
| 50-Day Moving Average | 0.38 AUD |
| 200-Day Moving Average | 0.4 AUD |
OCC.AX Share Statistics
| Avg. Volume (3 month) | 107.92K AUD |
| Avg. Daily Volume (10-Days) | 114.68K AUD |
| Shares Outstanding | 197.3M |
| Float | 153.5M |
| Short Ratio | N/A |
| % Held by Insiders | 23.15% |
| % Held by Institutions | 2.91% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -679.46% |
| Gross Margin | 57.17% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -29.021% |
| Return on Equity (ttm) | -83.44% |
Income Statement
| Revenue (ttm) | 1.61M AUD |
| Revenue Per Share (ttm) | 0.008 AUD |
| Quarterly Revenue Growth (yoy) | 10.80% |
| Gross Profit (ttm) | 829.11K AUD |
| EBITDA | -10743317 AUD |
| Net Income Avi to Common (ttm) | -8509507 AUD |
| Diluted EPS (ttm) | -0.04 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 26.82M AUD |
| Total Cash Per Share (mrq) | 0.14 AUD |
| Total Debt (mrq) | 490.89K AUD |
| Total Debt/Equity (mrq) | 7.91 AUD |
| Current Ratio (mrq) | 6.368 |
| Book Value Per Share (mrq) | 0.031 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 14.3M AUD |
| Levered Free Cash Flow (ttm) | -4713795 AUD |
Profile of Orthocell Limited
| Country | Australia |
| State | WA |
| City | Murdoch |
| Address | Building 191 |
| ZIP | 6150 |
| Phone | 61 8 9360 2888 |
| Website | https://orthocell.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia. The company offers CelGro, a naturally derived collagen medical device for use in multiple indications to augment the surgical repair of bone, peripheral nerves, tendons, and cartilage; and Ortho-ATI, a cell therapy for treatment of chronic tendon injuries. It also provides Ortho-ACI, an autologous chondrocyte implantation to treat articular cartilage defects in the knee and ankle; Striate+, a resorbable collagen membrane used for guided bone and tissue regeneration in dental application; and Remplir, a collagen scaffold used in peripheral nerve repair. Orthocell Limited was incorporated in 2006 and is headquartered in Murdoch, Australia.
Q&A For Orthocell Limited Stock
What is a current OCC.AX stock price?
Orthocell Limited OCC.AX stock price today per share is 0.38 AUD.
How to purchase Orthocell Limited stock?
You can buy OCC.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Orthocell Limited?
The stock symbol or ticker of Orthocell Limited is OCC.AX.
Which industry does the Orthocell Limited company belong to?
The Orthocell Limited industry is Biotechnology.
How many shares does Orthocell Limited have in circulation?
The max supply of Orthocell Limited shares is 209.33M.
What is Orthocell Limited Price to Earnings Ratio (PE Ratio)?
Orthocell Limited PE Ratio is now.
What was Orthocell Limited earnings per share over the trailing 12 months (TTM)?
Orthocell Limited EPS is -0.04 AUD over the trailing 12 months.
Which sector does the Orthocell Limited company belong to?
The Orthocell Limited sector is Healthcare.